These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evolutionary biology of a Lassa virus complex. Gonzalez JP; Georges AJ; Kiley MP; Meunier DM; Peters CJ; McCormick JB Med Microbiol Immunol; 1986; 175(2-3):157-9. PubMed ID: 3724662 [No Abstract] [Full Text] [Related]
6. Serological and biological evidence that Lassa-complex arenaviruses are widely distributed in Africa. Kiley MP; Swanepoel R; Mitchell SW; Lange JV; Gonzalez JP; McCormick JB Med Microbiol Immunol; 1986; 175(2-3):161-3. PubMed ID: 3724663 [No Abstract] [Full Text] [Related]
7. Preparation and use of erythrocyte-globulin conjugates to Lassa virus in reversed passive hemagglutination and inhibition. Goldwasser RA; Elliott LH; Johnson KM J Clin Microbiol; 1980 Jun; 11(6):593-9. PubMed ID: 7000810 [TBL] [Abstract][Full Text] [Related]
8. [The indirect hemagglutination reaction for the detection of the Lassa virus]. Vladyko AS; Kramarenko LP; Cherednichenko IA; Surikova LE Vopr Virusol; 1988; 33(4):498-502. PubMed ID: 3195147 [No Abstract] [Full Text] [Related]
9. Serology and virulence diversity among Old-World arenaviruses, and the relevance to vaccine development. Jahrling PB; Peters CJ Med Microbiol Immunol; 1986; 175(2-3):165-7. PubMed ID: 3724664 [No Abstract] [Full Text] [Related]
10. Antibodies to Lassa and Lassa-like viruses in man and mammals in the Central African Republic. Georges AJ; Gonzalez JP; Abdul-Wahid S; Saluzzo JF; Meunier DM; McCormick JB Trans R Soc Trop Med Hyg; 1985; 79(1):78-9. PubMed ID: 2986324 [TBL] [Abstract][Full Text] [Related]
11. [Dynamics of antigen and antibody accumulation in adult mice, infected with Lassa virus]. Vladyko AS; Surikova LE; Kramarenko LP; Bystrova SI; Torop AV Vopr Virusol; 1989; 34(1):100-3. PubMed ID: 2658319 [No Abstract] [Full Text] [Related]
12. [Characteristics of monoclonal antibodies against Lassa virus]. Vladyko AS; Bystrova SI; Lemeshko NN; Lukashevich IS Mol Gen Mikrobiol Virusol; 1987 May; (5):37-40. PubMed ID: 2441254 [TBL] [Abstract][Full Text] [Related]
13. Modifications to indirect immunofluorescence tests on Lassa, Marburg, and Ebola material. van der Groen G; Kurata T; Mets C Lancet; 1983 Mar; 1(8325):654. PubMed ID: 6131336 [No Abstract] [Full Text] [Related]
14. Possible approaches to a vaccine against Lassa fever. Clegg JC Trans R Soc Trop Med Hyg; 1984; 78(3):307-10. PubMed ID: 6464128 [No Abstract] [Full Text] [Related]
15. Use of betapropionolactone inactivated Ebola, Marburg and Lassa intracellular antigens in immunofluorescent antibody assay. Van der Groen G; Elliot LH Ann Soc Belg Med Trop; 1982 Mar; 62(1):49-54. PubMed ID: 7049096 [No Abstract] [Full Text] [Related]
16. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever. Clegg JC; Lloyd G Lancet; 1987 Jul; 2(8552):186-8. PubMed ID: 2885642 [TBL] [Abstract][Full Text] [Related]
17. Serological survey for the detection of antibodies to lassa virus in India. Rodrigues FM; Gupta NP; Pinto BD J Indian Med Assoc; 1978 Jan; 70(2):25-8. PubMed ID: 659905 [No Abstract] [Full Text] [Related]
18. Lassa fever antibodies in hospital personnel in the Plateau State of Nigeria. Fabiyi A; Tomori O; Pinneo P Niger Med J; 1979 Jan; 9(1):23-5. PubMed ID: 463337 [No Abstract] [Full Text] [Related]
19. Differentiation between two African arenaviruses (Lassa and Mozambique) by plaque assay. Tomori O; Johnson K Acta Virol; 1987 Mar; 31(2):146-51. PubMed ID: 2886023 [TBL] [Abstract][Full Text] [Related]
20. Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Jahrling PB; Frame JD; Smith SB; Monson MH Trans R Soc Trop Med Hyg; 1985; 79(3):374-9. PubMed ID: 3898483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]